| 2015-04-10 |
Nancy J. Hutson, Ph.D. was appointed to the Board in January 2012. Dr. Hutson currently serves on the Board of Directors for Endo Pharmaceuticals Holdings, Inc. She also previously served on the Board of Directors of Inspire Pharmaceuticals, Inc. and Cubist Pharmaceuticals, Inc. The Corporate Governance and Nominating Committee consisting of Dr. Hutson, as its Chairwoman, Dr. Jensen and Mr. Abercrombie. The 2014 Director Compensation table shows Nancy J. Hutson, Ph.D. received total compensation of $131,738. |
| 2018-09-28 |
The following table provides information related to the compensation of our non-employee directors during fiscal 2017.
| Name
| Fees Earned ($)
| Option Award ($) (1) (2)
| Non-Equity Incentive Plan Compensation
| All Other Compensation
| Total ($)
|
| Nancy J. Hutson, Ph.D.
| 65,000 | (3)
| 104,664
| -
| -
| 169,664 |
| 2019-04-17 |
Nancy J. Hutson, Ph.D. was appointed to the Board in January 2012. ... The Company has a Compensation Committee, currently consisting of Dr. Hutson, as its Chairwoman, Mr. Ingram and Mr. Aselage. ... The Company has a Corporate Governance and Nominating Committee consisting of Mr. Abercrombie, as its Chairman, Dr. Hutson, and Mr. Ingram. |
| 2020-03-31 |
Nancy J. Hutson, Ph.D. was appointed to the Board in January 2012. Dr. Hutson brings over 30 years of experience as a seasoned professional and leader within the pharmaceutical industry. ... The Company has a Compensation Committee, currently consisting of Dr. Hutson, as its Chairwoman, Mr. Ingram and Mr. Aselage. The Compensation Committee is responsible for the annual review of officer compensation and other incentive programs. ... The Company has a Corporate Governance and Nominating Committee consisting of Mr. Abercrombie, as its Chairman, Dr. Hutson, and Mr. Ingram. ... 2019 DIRECTOR COMPENSATION ... The following table provides information related to the compensation of our non-employee directors during fiscal 2019. ... Nancy J. Hutson, Ph.D. 75,000 59,088 – – 134,085 ... The Compensation Committee currently consists of Dr. Hutson, as its Chairwoman, Mr. Ingram and Mr. Aselage. |
| 2021-04-13 |
Nancy J. Hutson, Ph.D. was initially appointed to the Board in January 2012. Dr. Hutson brings over 30 years of experience as a seasoned professional and leader within the pharmaceutical industry. ... Dr. Hutson currently serves on the Board of Directors for Endo International plc, a publicly traded pharmaceutical company, and PhaseBio Pharmaceuticals, Inc. and Clearside Biomedical, Inc., both publicly traded biopharmaceutical companies. ... The Company has a Compensation Committee, currently consisting of Dr. Hutson, as its Chairwoman, Mr. Aselage, and Mr. Ingram. ... The Company has a Corporate Governance and Nominating Committee consisting of Mr. Abercrombie, as its Chairman, Dr. Hutson, and Mr. Ingram. ... 2020 DIRECTOR COMPENSATION ... Nancy J. Hutson, Ph.D. 221,560 |
| 2023-04-27 |
Nancy J. Hutson, Ph.D. was elected as Chair of the Board in March 2023... The Company’s Compensation Committee currently consists of Dr. Hutson, as its Chair, Mr. Aselage, and Ms. Sanders (since February 2023)... 2022 Director Compensation: Nancy J. Hutson, Ph.D. total compensation $444,848. |
| 2023-04-27 |
Nancy J. Hutson, Ph.D. was initially appointed to the Board in January 2012 and was elected as Chair of the Board in March 2023... The Company’s Compensation Committee currently consists of Dr. Hutson, as its Chair, Mr. Aselage, and Ms. Sanders (since February 2023)... 2022 Director Compensation: Nancy J. Hutson, Ph.D. total compensation $444,848. |
|